About Alizé Pharma
Alizé Pharma is a company based in Ecully (France) founded in 2007 was acquired by Millendo Therapeutics in December 2017.. Alizé Pharma has raised $94.35 million across 7 funding rounds from investors including Crédit Agricole, Orbimed and Bpifrance. Alizé Pharma offers products and services including Enhertu and AstraZeneca Vaccines.
- Headquarter Ecully, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$94.35 M (USD)
in 7 rounds
-
Latest Funding Round
$75 M (USD), Series A
Jul 31, 2019
-
Investors
Crédit Agricole
& 14 more
-
Employee Count
Employee Count
-
Acquired by
Millendo Therapeutics
(Dec 20, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alizé Pharma
Alizé Pharma offers a comprehensive portfolio of products and services, including Enhertu and AstraZeneca Vaccines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets HER2-positive metastatic breast cancer for improved progression-free survival
Develops vaccines and therapies for infectious diseases and immune protection
Funding Insights of Alizé Pharma
Alizé Pharma has successfully raised a total of $94.35M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $75 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $75.0M
-
First Round
First Round
(18 Sep 2007)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series A - Alizé Pharma | Valuation | Life Sciences Partners | |
| Mar, 2015 | Amount | Series A - Alizé Pharma | Valuation |
investors |
|
| Sep, 2014 | Amount | Series A - Alizé Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alizé Pharma
Alizé Pharma has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, Orbimed and Bpifrance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Biotech startups are funded through venture capital in life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alizé Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alizé Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alizé Pharma Comparisons
Competitors of Alizé Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alizé Pharma
When was Alizé Pharma founded?
Alizé Pharma was founded in 2007.
Where is Alizé Pharma located?
Alizé Pharma is headquartered in Ecully, France. It is registered at Ecully, Auvergne-rhone-alpes, France.
Is Alizé Pharma a funded company?
Alizé Pharma is a funded company, having raised a total of $94.35M across 7 funding rounds to date. The company's 1st funding round was a Series A of $6.44M, raised on Sep 18, 2007.
What does Alizé Pharma do?
Alizé Pharma was established in 2007 in Ecully, France, within the biotechnology sector. Emphasis is placed on the development of drugs, proteins, and peptides targeted at metabolic and rare diseases. Research and development operations are conducted to create therapeutic solutions for these conditions, with activities focused on addressing specific unmet needs in patient care across Europe.
What products or services does Alizé Pharma offer?
Alizé Pharma offers Enhertu and AstraZeneca Vaccines.
Who are Alizé Pharma's investors?
Alizé Pharma has 15 investors. Key investors include Crédit Agricole, Orbimed, Bpifrance, Kurma Partners, and Life Sciences Partners.